ArticleBiochemical genetics2026
Circ_0001461 Regulates Colorectal Cancer Growth, Movement and Immune Escape Through miR-532-3p/AMOTL2.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC), as a common malignant tumor of gastrointestinal tract, has become one of the important diseases threatening human health. Circ_0001461 has been proven to be closely associated with the occurrence and development of various cancers. This study explored the function and possible mechanism of circ_0001461 in CRC. The RNA expression level was detected using qRT-PCR. The viability, apoptosis or invasion ability of CRC cells were explored by CCK-8, flow cytometry or Transwell experiment, respectively. The protein expression level in cells was analyzed by Western blot (WB). IFN-γ, IL-2 or TNF-α levels were investigated via ELISA experiment. The targeting relationship between circ_0001461, miR-532-3p and AMOTL2 was confirmed via dual-luciferase reporter experiment, RNA pull-down experiment and RIP assay. The protein expression in tissues was explored by IHC staining. Tumor volumes, body weights, tumor weights and apoptosis levels were detected in xenograft mouse model. Circ_0001461 was greatly expressed in CRC samples and was associated with poor prognosis. Silencing circ_0001461 reduced cell proliferation, increased cell apoptosis rate, decreased invasion ability and inhibited immune escape in vitro. Additionally, silencing circ_0001461 prominently shortened the tumor volume and tumor weight in vivo. Circ_0001461 targeted miR-532-3p to regulate AMOTL2 expression. AMOTL2 was the downstream targets of miR-532-3p. Downregulation of miR-532-3p or overexpression of AMOTL2 abolished the effect of silencing circ_0001461. Collectively, our research demonstrated that the circ_0001461 played a certain regulatory role in growth, movement and immune escape of colon cancer via miR-532-3p/AMOTL2 axis.
Indexed as
Identifiers
40569478What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.